Events
Biogen Golden Ticket Application
Applications are now open for the 2026 Biogen Golden Ticket!
On top of $50,000 in funding for space at LabCentral, winners also gain access to state-of-the-art shared infrastructure and community. Each Golden Ticket company will also be paired with an innovation partner from Biogen, receiving guidance from a global pioneer in innovation!
Biogen is looking for high-potential early-stage startups that leverage cutting-edge science to develop first-in-class, transformative medicines, with particular interest in Neurology, Immunology, Nephrology, Ophthalmology, Rare diseases, as well as tissue delivery and target discovery innovations. Areas out of scope include Oncology, Infectious diseases, and vaccines.
What are you waiting for? Apply today! Details and eligibility criteria are below 👇